Flat panel detector (FPD) based x-ray for cone beam computed tomography (CBCT) market size reach USD 3.96 billion by 2025

The global flat panel detector (FPD) based x-ray for cone beam computed tomography (CBCT) market size is likely to reach USD 3.96 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 8.07% during the forecast period. Rising adoption of 3D imaging in medical diagnostics and application of FPD in a substantial number of CBCT systems is expected to spur the growth of the market during the forecast period.

Most of the commercially available CBCT devices operate on principle of indirect FPDs, where X-ray photons are converted to light photons using a layer of scintillator material (Caesium Iodide (CsI:Tl) or Gadolinium Oxysulfide (Gd2O2S:Tb)). These light photons are further converted into electrical signals. Higher dose efficiency and image quality are achieved using modern CsI scintillators as their columnar structure reduces the light spreading between the scintillators.

The FPD-based X-ray for CBCT market is consolidated, marked by presence of a few well-established players that account for the largest cumulative revenue share. These players have strengthened their presence by improving distribution network. However, with increasing market opportunities, the number of new entrants is estimated to rise gradually. Established players are adopting strategies such as development of a strong product line with innovative designs and expansion of service facilities on a global scale.

For instance, in April 2018, Xoran Technologies launched MiniCAT 2020, a compact, low-dose, and CBCT scanner. This product was introduced for diagnosis of sinus disease. Xoran entered the CBCT market in 2001. Furthermore, in November 2016, AFP Imaging Corporation received a license from the Canadian government for marketing of Newtom VG 3D CBCT scanner. In May 2015, PLANMED OY received FDA approval for its new CBCT system-based on FPD technology, Planmed Verity MaxScan, which is designed for maxillofacial imaging.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/fpd-based-x-ray-cbct-market

Further key findings from the report suggest:

• Orthopedics dominated the FPD-based X-ray CBCT market in 2017, owing to higher adoption of the technology for orthopedic imaging. Growing number of medical X-ray imaging for extremity application is further contributing to the growth of the segment
• With high complexity in imaging due to small and complicated bone structures in ENT, this application segment is projected to post the highest CAGR in terms of revenue during the forecast period
• FPD-based CBCT with standing patient positioning accounted for largest share in the market in 2017, due to benefits associated with their usage, including low cost, less space occupied, and higher preference for orthopedic imaging
• Hospitals represented the leading revenue share in 2017 as a consequence of higher demand from these end users for detection of anomalies and deformities prior and post surgeries
• In 2017, North America dominated the market owing to volumetric expansion of product usage coupled with presence of well-established market participants
• However, Middle East & Africa is anticipated to exhibit the fastest CAGR during the forecast period owing to increased import and installation of radiographic units in these countries
• Prominent companies operating in this market include Xoran Technologies, LLC, Ray, PLANMECA OY, VATECH, i-CAT, Dentsply Sirona, Owandy Radiology, Danaher (KaVo Kerr, Gendex, PaloDEx Group), Cefla S.C. (NewTom S.C), and J. MORITA CORP.

Veterinary Surgical Instruments Market Geographic Regional Analysis by Product Type, Applications, Forecast to 2025

The global veterinary surgical instrument market size is expected to reach USD 1.33 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 6.8% during the forecast period. Surging demand for pet adoption is estimated to drive the market during the forecast period. Increasing income in developing countries has also driven the market. For instance, according to a report by the American Veterinary Medical Association, in 2017, around 46.0% household had multiple types of pets in the U.S. Furthermore, key players implement strategies such as mergers and acquisitions to sustain in this competitive market. For instance, in 2014, Neogen Corporation acquired SyrVet Incorporated and Prima Tech Incorporated in a probe to expand its product portfolio.

Moreover, technological advancements in surgical devices and availability of a number of detection techniques are anticipated to create growth opportunities for the market. Some of these are micro fracture detection, laparoscopy, and 3D printing. For instance, in October 2016, Surgical Holdings launched reusable surgical instruments for general surgeries in an attempt to cut the cost of the instruments.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/veterinary-surgical-instruments-market

Further key findings from the report suggest:

• Handheld devices accounted for the largest revenue share in 2017, owing to their multipurpose use and ease of handling
• On the basis of animal type, the small animal segment is projected to exhibit lucrative growth over the forecast period owing to growing incidence of pet adoption and surging demand for efficient care
• Based on application, the dental surgery segment is poised to dominate the market throughout the forecast period due to increasing prevalence of periodontal diseases and rising demand for pet dental cure
• North America held the dominant position in the global arena in 2017, due to favorable pet insurance policies and new product launch by companies. For instance, in February 2016, DRE Veterinary launched a new radiology unit named DRE Stationary DR X-ray System
• Asia Pacific is anticipated to witness lucrative growth during the forecast period due to rising demand for pet adoption and growing income, especially in Japan and India
• Some of the key companies in the market are Medtronic, DRE Veterinary, B. Braun Vet Care GmbH, and Jorgen Kruuse A/S.

Surgical Microscopes With Emerging Trends, Product Scope, and Demand Between 2018 to 2025

The global surgical microscopes market size is expected to reach USD 1.3 billion by 2025, according to a new study by Grand View Research, Inc. It is anticipated to register a CAGR of 11.5% over the forecast period. Prevalence of chronic disorders such as cancer and Coronary Heart Disease (CHD) requires surgery as the prime line of treatment. With the advent of operating microscopes, these surgeries have become easier and less painful; thus, these devices are a preferred choice for the treatment of chronic conditions. This factor is anticipated to bode well for market growth in near future.

The inflow of technologically-advanced products is projected to spur the demand for surgical microscopes as they are accurate and offer better illumination and stability. Technologies such as red reflex illumination stability, wide angle illumination, and augmented microscopy act as emerging technologies. Rising popularity of minimally invasive surgeries due to their patient-friendly nature is an impact rendering driver for this market. Operating microscopes are vital elements of minimally invasive procedures as well as microsurgeries, fueling growth of the surgical microscopes market.

Mergers and acquisitions along with new product launches are some of the key strategic initiatives undertaken by market players to sustain the competition. Upgrading of products, new launches, technological innovation, and strategic collaborations are the key initiatives. For instance, in August 2014, Alcon acquired WaveTec Vision, a developer of an intraoperative guidance system for cataract. This initiative helped Alcon to strengthen product portfolio in the ophthalmic surgical market.

 To request a sample copy or view summary of this report, click the link below: 

https://www.grandviewresearch.com/industry-analysis/surgical-microscopes-market

Further key findings from the study suggest:

• Oncology held lucrative market share in the application segment in 2017, owing to rising prevalence of cancer along with the complexity of treatment
• Neurosurgery and spinal surgeries are anticipated to witness lucrative growth over the forecast period, owing to increasing R&D investments
• The surgical microscopes based on casters are expected to continue leading the type segment over the forecast period, due to their portability and easy cleaning capabilities
• Hospital, as an end-user segment, held the largest market share in 2017. Greater financing capabilities and increased volume of surgeries contributed to this growth
• Physician’s/dentists’ clinic as end-user is anticipated to expand at a substantial CAGR, owing to the availability of small-scale microscopes and growth of cosmetic dentistry
• North America held lucrative market shares of around 39.0% in 2017. On the contrary, Asia Pacific is anticipated to witness lucrative growth over the forecast period. Unmet needs of huge population base along with economic development in this region governed its growth
• The key players operating in the surgical microscopes market include Carl Zeiss, Leica Microsystems, Allition (Wuzhou), Takagi Corporation, Topcon, Alcon, HAAG-STREIT SURGICAL, and Seiler Precision Microscopes.

Global Breast Imaging Devices Market Trends, Designs, Growth Factors & Applications

The global breast imaging market is expected to reach USD 7.3 billion by 2024, according to a new report by Grand View Research, Inc. The increasing incidences of breast cancer coupled with the continual product improvements being launched and the numerous R&D innovation initiatives being undertaken in the field of cancer are expected to collectively boost the growth of the market over the forecast period.

In 2012, the WHO estimated that around 53.0% of the global women population (1.8 billion women) is anticipated to suffer from breast cancer over their lifespan. This alarmingly rising rate is expected to be the preliminary driver for this market over the forecast period.

The rising base of the geriatric population is another high impact rendering driver of the breast imaging market. A study by the NCBI (National Center for Biotechnology Information) stated that the incidence of breast cancer is higher in patients above the age group of 45.

Increasing expenditure on R&D coupled with government funding are the other vital factors expected to trigger market growth over the forecast period. In 2013, the National Institute of Health, in the U.S. provided a grant amounting to USD 5.6 billion to conduct research on breast cancer. Digital mammography is one of the technologies gaining popularity as compared to other technologies, which is expected to positively reinforce this market’s growth.

However, the high cost of the existing imaging systems coupled with the stringent regulatory policies governing the approval of new products and marketing are predicted to slowdown growth.

View summary of this report, Click Here 

Further key findings from the study suggest:

• The 3D tomosynthesis segment is identified as the fastest growing segment. This technology offers enhanced efficiency and higher diagnostic accuracy in comparison to other available technologies, which is expected to aid market growth.
• North America is likely to dominate throughout the forecast period with a revenue share of over 30.0% by 2024.Government initiatives including the precision medicine initiative, started by President Obama in 2015, promotes the development of personalized medicine, which is anticipated to foster market growth.
• Asia Pacific is anticipated to grow at the fastest rate of12.0% over the forecast period. The Increasing number of investments in the healthcare sector coupled with the rising awareness of breast cancer and other associated conditions is anticipated to propel the market growth in this region.
• Some major players of the market are Siemens Healthcare, GE Healthcare, Dilon Technologies, Inc., Hologic, Inc., Gamma Medica, Inc., Fujifilm Holdings Corporation, SonoCine, Inc., Philips Healthcare, Toshiba Corporation, and Aurora Imaging Technology, Inc.
• In order to gain a competitive advantage in the market, the key industry players are adhering to mergers, acquisitions and collaborative agreements. For instance, in January 2016, Gamma Medica, Inc. entered into a contract with Alpha Imaging Technology Corp. for the commercialization of its new product, Luma GEM.

Click Here For Continue Reading : https://goo.gl/RHH9HZ

Sample Request of this Report : sales@grandviewresearch.com

Portable CT scan and X-ray device market are expected to reach USD 8.41 billion by 2020

The global portable CT scan and X-ray device market are expected to reach USD 8.41 billion by 2020. Increasing demand for home healthcare, bedside imaging, and growing use of CT scan to assess the accuracy of medical implants, post interventional medical procedures and anatomical confirmation are key factors driving industry growth.

Rising prevalence of diseases such as cancer, cardiovascular, dental and orthopedic disorder will also augment the growth of the market. Also, an increase in the number of medical implants surgeries owing to unhealthy lifestyle as well as growing base of geriatric population is expected to bolster demand.

The portable X-ray device were dominated by mobile X-ray machines on account of rising demand for core diagnostic and bedside imaging. These device also eliminate the requirement for multiple radiology departments in a healthcare institution, thus promoting industry growth. The handheld X-Ray device market is poised to experience substantial growth over the forecast period owing to high maneuverability and the introduction of products such as NOMAD Pro.

Portable CT scan device market was dominated by the medium slice scanners due to high image resolution capabilities and high usage rates. Medium slice scanner accounted for over 58% of portable CT scan by technology in 2013. Digital radiography, owing to increasing demand for manufacturing filmless X-ray and PACS based radiology device, is identified as the fastest growing technology among the overall market.

View summary of this report, Click Here

North America is expected to dominate the market demand for these device over the forecast period owing to high expenditure on healthcare, reimbursement framework and sophisticated healthcare infrastructure. However, Asia Pacific is expected to witness the fastest growth, growing at a CAGR of more than 9% owing to improving healthcare infrastructure particularly in emerging economies such as China and India. In addition, the advent of technologically advanced and economical products catering to cost sensitive clientele in the region will fuel the growth of the market.

Supportive government regulations in Asia Pacific promoting manufacturing in the region is expected to drive demand for portable medical machines. Furthermore, low labor cost coupled with abundant tier I companies is projected to propel portable medical machines manufacturing in the region. As a result, product cost is likely to decrease over the forecast period owing to technological advancements which in turn is expected to drive demand, particularly in the emerging economies.

Philips Healthcare was the dominant player in the portable X-ray machines market with a market share of over 17% in 2013. Philips possessed an extensive product portfolio ranging from stationary X-ray systems to digital and portable X-ray systems. Some of the other key players in the industry are Hitachi Medical Systems and Varian Medical Systems, GE Healthcare, and Siemens Healthcare.

Get Full Detail At : https://goo.gl/CtJML4

Preclinical imaging market size is expected to reach around USD 3.6 billion by the year 2024

The global preclinical imaging market is expected to reach around USD 3.6 billion by the year 2024, according to a report performed by Grand View Research, Inc. The swift increase in the number of clinical research organizations (CROs), pharmaceutical companies, and research and development organizations is propelling the demand for preclinical imaging.

Heavy investments in research and development are encouraging research projects worldwide. As a result, the demand for Preclinical imaging is steadily increasing. Pharmaceuticals, biotechnology, life sciences, medical devices, and cosmetics are the wide application areas, where imaging modalities are widely used in research and development. Furthermore, veterinary hospitals and educational institutions also create an additional demand for this market.

North America comprises the U.S. and Canada markets. North America and Europe together accounted for the largest market share in 2015. The increased research and development funding coupled with the presence of a highly developed research infrastructure is accelerating the growth of the market in Europe and North America.

On the other hand, the governing stringent regulatory guidelines are restricting the growth of the market in North America. Asia Pacific is expected to show the fastest growth rate during the forecast period owing to the easy availability of resources, the presence of an advanced research infrastructure, and the allocation of government funds for R&D activities.

View summary of this report, click the link below: 
http://www.grandviewresearch.com/industry-analysis/preclinical-imaging-market

Further key findings from the study suggest:

• The optical imaging devices segment captured the largest market share of the overall market in 2015. The largest market share was mainly attributed to the extensive application of these devices in small animal imaging and research projects.
• The multimodal imaging devices segment is anticipated to show a significant growth rate from 2016 to 2024. The increasing adoption of these devices owing to the integration of multiple imaging modalities into a single unit is the major factor expected to drive the growth of this segment during the forecast period.
• The reagents segment accounted for a significant market share in 2015 as these products are purchased repeatedly, unlike in the case of imaging devices
• North America captured the largest market share of around 35% in 2015. The market is expected to maintain its dominance during the forecast period. Well-established research infrastructure, the growing number of research and development activities, and the rising investments in R&D are some of the factors supporting the growth of the market in this region.
• Asia Pacific is anticipated to show a significant growth rate from 2016 to 2024 owing to the rapidly expanding contract research organization (CRO) industry in this region
• The exit of the major players from the market is creating growth opportunities for the other smaller, domestic Preclinical imaging system manufacturers
• The major market players include Bruker Corporation, Siemens A.G., General Electric(GE), TriFoil Imaging, PerkinElmer, Inc., VisualSonics, Inc. (Fujifilm), Mediso Ltd., MILabs B.V., and Agilent Technologies.

Reference Links: 

http://www.grandviewresearch.com/industry-analysis/preclinical-imaging-market

Breast imaging market is expected to reach USD 7.3 billion by 2024

The global breast imaging market is expected to reach USD 7.3 billion by 2024, according to a new report by Grand View Research, Inc. The increasing incidences of breast cancer coupled with the continual product improvements being launched and the numerous R&D innovation initiatives being undertaken in the field of cancer are expected to collectively boost the growth of the market over the forecast period.

In 2012, the WHO estimated that around 53.0% of the global women population (1.8 billion women) is anticipated to suffer from breast cancer over their lifespan. This alarmingly rising rate is expected to be the preliminary driver for this market over the forecast period.

The rising base of the geriatric population is another high impact rendering driver of the breast imaging market. A study by the NCBI (National Center for Biotechnology Information) stated that the incidence of breast cancer is higher in patients above the age group of 45.

Increasing expenditure on R&D coupled with government funding are the other vital factors expected to trigger market growth over the forecast period. In 2013, the National Institute of Health, in the U.S. provided a grant amounting to USD 5.6 billion to conduct research on breast cancer. Digital mammography is one of the technologies gaining popularity as compared to other technologies, which is expected to positively reinforce this market’s growth.

However, the high cost of the existing imaging systems coupled with the stringent regulatory policies governing the approval of new products and marketing are predicted to slowdown growth.

view summary of this report, click the link below: 
http://www.grandviewresearch.com/industry-analysis/breast-imaging-equipment-market

Further key findings from the study suggest:

• The 3D tomosynthesis segment is identified as the fastest growing segment. This technology offers enhanced efficiency and higher diagnostic accuracy in comparison to other available technologies, which is expected to aid market growth.
• North America is likely to dominate throughout the forecast period with a revenue share of over 30.0% by 2024.Government initiatives including the precision medicine initiative, started by President Obama in 2015, promotes the development of personalized medicine, which is anticipated to foster market growth.
• Asia Pacific is anticipated to grow at the fastest rate of12.0% over the forecast period. The Increasing number of investments in the healthcare sector coupled with the rising awareness of breast cancer and other associated conditions is anticipated to propel the market growth in this region.
• Some major players of the market are Siemens Healthcare, GE Healthcare, Dilon Technologies, Inc., Hologic, Inc., Gamma Medica, Inc., Fujifilm Holdings Corporation, SonoCine, Inc., Philips Healthcare, Toshiba Corporation, and Aurora Imaging Technology, Inc.
• In order to gain a competitive advantage in the market, the key industry players are adhering to mergers, acquisitions and collaborative agreements. For instance, in January 2016, Gamma Medica, Inc. entered into a contract with Alpha Imaging Technology Corp. for the commercialization of its new product, Luma GEM.

Reference Links:

http://www.grandviewresearch.com/industry-analysis/breast-imaging-equipment-market